InvestorsHub Logo
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Re: None

Tuesday, 06/09/2015 7:22:51 AM

Tuesday, June 09, 2015 7:22:51 AM

Post# of 5007
This is not just patent news read this

" Importantly, this patent expands the scope of RXi's self-delivering RNAi platform with the incorporation of novel oligonucleotide chemical modifications. These chemical modifications result in improved biodistribution following systemic administration and may be beneficial for local delivery applications in the central nervous system."

That means Rxi just improved its sd-rxRNA technology platform for systemic diseases with chemical modifications. Also improved local delivery for Central nervous system diseases.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PHIO News